| dc.creator | Canessa G,José A | |
| dc.creator | Larach K,Jorge A | |
| dc.creator | Massardo V,Teresa | |
| dc.creator | Parra Z,Juan | |
| dc.creator | Jofré M,Josefina | |
| dc.creator | González E,Patricio | |
| dc.creator | Morales C,Bernardo | |
| dc.creator | Humeres A,Pamela | |
| dc.creator | Sierralta C,Paulina | |
| dc.creator | Galaz B,Rodrigo | |
| dc.date | 2004-03-01 | |
| dc.date.accessioned | 2019-11-14T12:59:19Z | |
| dc.date.available | 2019-11-14T12:59:19Z | |
| dc.identifier | https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872004000300010 | |
| dc.identifier.uri | https://revistaschilenas.uchile.cl/handle/2250/119407 | |
| dc.description | We report a 38 years old female patient with a pancreatic mucinous cystadenocarcinoma. She presented at the onset with a peritoneal rupture that required emergency surgery. Five months later, the patient was subjected to a segmental pancreatectomy and splenectomy. One year later, the patient had a serious gastric bleeding secondary to a gastric ulcer. Due to a persistent increase in her CA 19-9 levels, a Positron Emission Tomography (PET) functional imaging with fluorine 18-deoxyglucose (F18FDG) was done. It showed an intense focal hypermetabolism in the gastric wall reported as a secondary tumour location. The patient was subjected to a total gastrectomy and Roux en Y anastomosis, with a good outcome. The pathological study confirmed the presence of a metastasis of an adenocarcinoma in the gastric wall. The relative value of CA 19-9 markers and FDG PET in pancreatic and gastric carcinomas is discussed (Rev Méd Chile 2004; 132: 347-52). | |
| dc.format | text/html | |
| dc.language | es | |
| dc.publisher | Sociedad Médica de Santiago | |
| dc.relation | 10.4067/S0034-98872004000300010 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.source | Revista médica de Chile v.132 n.3 2004 | |
| dc.subject | CA-19-9 antigen | |
| dc.subject | Pancreatic neoplasms | |
| dc.subject | Tomography, emission-computed | |
| dc.title | Estudio de imágenes PET con Flúor18-Desoxiglucosa (F18FDG) en evaluación de elevación de marcador tumoral CA 19-9 en paciente con cistoadenocarcinoma mucinoso de páncreas | |
